|
1. Bousquet J, Khaltaev N. Global alliance against chronic respiratory
diseases. GARD. Geneva WHO 2007
2. Settipane RA, Lieberman P. Update on nonallergic rhinitis.
Ann Allergy Asthma Immunology 2001;86:494–507
3. 黃璟隆， 從台灣過敏病的增加談衛生假說。台灣兒童過敏氣喘
及免疫學會通訊2003;4(2):16-17
4. Bauchau V, Durham SR. Prevalence and rate of diagnosis of
allergic rhinitis in Europe. European Respiratory Journal
2004;24:758-764
5. Blaiss MS. Allergic rhinitis and impairment issues in school
children: a consensus report. Current Med Res Opinion 2004;20:
1937–1952
6. Hamouda S, Karila C, Connault T, Scheinmann P, de Blic J.
Allergic rhinitis in children with asthma: a questionnaire-based
study. Clin Exp Allergy 2008;38:761– 766
7. Taramarcaz P, Gibson PG. The effectiveness of intranasal
corticosteriods in combined allergic rhinitis and asthma syndrome.
Clin Exp Allergy 2004;34:1883–1889
8. Demoly P, Allaert F-A, Lecasble M. ERASM. A
pharmacoepidemiologic survey on management of intermittent
allergic rhinitis in every day general medical practice in France.
Allergy 2002;57:546–554
9. Casale TB, Amin BV. Allergic rhinitis/asthma interrelationships.
Clin Rev Allergy Immunol 2001;21:27 49
10. Kay AB. Allergy and allergic diseases. First of two parts. New
England Journal of Medicine 2001; 344:30–37
11. Cruz AA, Popou T, Pawankar A, Annesi-Maesano I, Fokkens W,
Kemp J . Common characteristics of upper and lower airways in
rhinitis and asthma: ARIA update in collaboration with GA2LEN.
Allergy 2007;62(Suppl.84):1-41
12. 劉素琴，過敏性鼻炎的中醫藥治療進展山東中醫雜誌
2001;20(2)
13. Ryan D. Primary care: the cornerstone of diagnosis of allergic
rhinitis. Allergy 2008;63:981–989
14. Molgaard E, Thomsen SF, Lund T, Pedersen L, Nolte H, Backer
V .Differences between allergic and non allergic rhinitis in a large
sample of adolescents and adults. Allergy 2007;62: 1033–1037
15. Airaksinen GL, Tuomi T, Vanhanen M,Voutilainen R, Toskala
E. Evaluation of nasal challenges in the diagnostics of occupational
rhinitis. Rhinology 2007; 45:40–46
16. Greiner AN, Meltzer EO. Pharmacologic rationale for treating
allergic and nonallergic rhinitis. J Allergy Clin Immunol
2006;118:985–998
17. Maldonado M, Martı´nez A, Alobid I, Mullol J. The antrochoanal
polyp. Rhinology 2004;42:178–182
18. Kemp A, Bryan L. Perennial rhinitis. A common childhood
complaint. Med J Aust 1984; 141: 640–643
19. Andrew S. Kemp. Allergic Rhinitis. Pediatric Respiratory Reviews
2009; 10;63-68
20. Al Sayyad JJ, Fedorowicz Z, Alhashimi D, Jamal A. Topical
nasal steriods for intermittent and persistent allergic rhinitis in
children. Cochrane Database Syst Rev 2007; 24:CD003163
21. Berger WE, Nayak AS, Staudinger HW. Mometasone furoate
improve congestion in patients with moderate-to-severe seasonal
allergic rhinitis. Ann Pharmacother 2005; 39: 1984–1989
22. Anolik R, Nathan RA, Schenkel E, Danzig MR, Gates D, Varghese
S. Intranasal mometasone furoate alleviates the ocular symptoms
associated with seasonal allergic rhinitis: results of a post hoc
analysis. Int Arch Allergy Immunol 2008; 147: 323–330
23. Fokkens WJ, Scadding GK. Perennial rhinitis in the under 4 s: a
difficult problem to treat safely and effectively? A comparison of
intranasal fluticasone propionate and ketotifen in the treatment of
2-4-year-old children with perennial rhinitis. Pediatr Allergy
Immunol 2004; 15:261–266
24. Cave A, Arlett P, Lee E. Inhaled and nasal corticosteroids: factors
affecting the risks of systemic adverse effects. Pharmacol Ther
1999; 83: 153–179
25. Murphy K, Uryniak T, Simpson B, O’Dowd L. Growth velocity in
children with perennial allergic rhinitis treated with budesonide
aqueous nasal spray. Ann Allergy Asthma Immunol 2006; 96:
723–730
26. Kim KT, Rabinovitch N, Uryniak T, Simpson B, O’Dowd L,
Casty F. Effect of budesonide aqueous nasal spray on
hypothalamic-pituitary-adrenal axis function in children with
allergic rhinitis. Ann Allergy Asthma Immunol 2004; 93: 61–67
27. Allen DB, Meltzer EO, Lemanske RF, Jr., Philpot EE, Faris
MA, Kral KM. No growth suppression in children treated with the
maximum recommended dose of fluticasone propionate aqueous
nasal spray for one year. Allergy Asthma Proc 2002;23: 407–413
28. Schenkel EJ, Skoner DP, Bronsky EA, Miller SD, Pearlman DS,
Rooklin A. Absence of growth retardation in children with
perennial allergic rhinitis after one year of treatment with
mometasone furoate aqueous nasal spray. Pediatrics 2000; 105:
E22
29. Rosenblut A, Bardin PG, Muller B, Faris MA, Wu WW, Caldwell
MF. Long-term safety of fluticasone furoate nasal spray in adults
and adolescents with perennial allergic rhinitis. Allergy
2007;62: 1071–1077
30. Scadding G. Optimal management of nasal congestion caused by
allergic rhinitis in children: safety and efficacy of medical
treatments Paediatr Drugs 2008; 10: 151–162
31. Turner P, Dear J, Scadding G, Foreman JC. Role of kinins in
seasonal allergic rhinitis: icatibant, a bradykinin B2 receptor
antagonist, abolishes the hyperresponsiveness and nasal
eosinophilia induced by antigen. J Allergy Clin Immunol 2001;
107:105–113
32. Simons FE. Prospective, long-term safety evaluation of the
H1-receptor antagonist cetirizine in very young children with
atopic dermatitis. ETAC Study Group. Early Treatment of the
Atopic Child. J Allergy Clin Immunol 1999; 104: 433–440
33. Meltzer EO, Scheinmann P, Rosado Pinto JE, Bachert C, Hedlin
G, Wahn U. Safety and efficacy of oral fexofenadine in children
with seasonal allergic rhinitis–a pooled analysis of three studies.
Pediatr Allergy Immunol 2004; 15: 253–260
34. Can D, Tanac R, Demir E, Gulen F, Veral A. Is the usage of
intranasal glucocorticosteroids alone in allergic rhinitis sufficient?
Allergy Asthma Proc 2006; 27: 248-253
35. Anolik R. Clinical benefits of combination treatment with
mometasone furoate nasal spray and loratadine vs monotherapy
with mometasone furoate in the treatment of seasonal allergic
rhinitis. Ann Allergy Asthma Immunol 2008; 100: 264–271
36. Ratner PH, Hampel F, Van Bavel J, Amar NJ, Daftary P,
Wheeler. Combination therapy with azelastine hydrochloride nasal
spray and fluticasone propionate nasal spray in the treatment of
patients with seasonal allergic rhinitis. Ann Allergy Asthma
Immunol 2008; 100: 74–81
37. Keskin O, Alyamac E, Tuncer A, Dogan C, Adalioglu G, Sekerel
BE. Do the leukotriene receptor antagonists work in children with
grass pollen-induced allergic rhinitis? Pediatr Allergy Immunol
2006;17:259–268
38. Chen ST, Lu KH, Sun HL, Chang WT, Lue KH, Chou MC.
Randomized placebocontrolled trial comparing montelukast and
cetirizine for treating perennial allergic rhinitis in children aged 2-6
yr. Pediatr Allergy Immunol 2006;17:49–54
39. Sheikh A, Hurwitz B, Shehata Y. House dust mite avoidance
measures for perennial allergic rhinitis. Cochrane Database Syst
Rev 2007;24:CD001563
40. Marks GB, Mihrshahi S, Kemp AS, Tovey ER, Webb K, Almqvist
C. Prevention of asthma during the first 5 years of life: a
randomized controlled trial. J Allergy Clin Immunolo
2006;118:53–61
41. Egmar AC, Emenius G, Almqvist C, Wickman M. Cat and do
allergen in mattresses and textile covered floors of homes which do
or do not have pets, either in the past or currently. Pediatr Allergy
Immunol 1998;9:31–35.
42. Roder E, Berger MY, de Groot H, van Wijk RG. Immunotherapy
in children and adolescents with allergic rhinoconjunctivitis: a
systematic review. Pediatr Allergy Immunol 2008;19:197–207
43. Wilson DR, Lima MT, Durham SR. Sublingual immunotherapy for
allergic rhinitis: systematic review and meta-analysis. Allergy
2005; 60: 4–12
44. Halken S, Lau S, Valovirta E. New visions in specific
immunotherapy in children: an iPAC summary and future trends.
Pediatr Allergy Immunol 2008; 19(Suppl 19): 60–70
45. Roder E, Berger MY, Hop WC, Bernsen RM, de Groot H, Gerth
VW. Sublingual immunotherapy with grass pollen is not effective
in symptomatic youngsters in primary care. J Allergy Clin
Immunol 2007; 119: 892–898
46. Wahn U, Tabar A, Kuna P, Halken S, Montagut A, de Beaumont O.
Efficacy and safety of 5-grass-pollen sublingual immunotherapy
tablets in pediatric allergic rhinoconjunctivitis. J Allergy Clin
Immunol 2009;123:160–166
47. van Wijk RG. Sublingual immunotherapy in children. Expert
Opin Biol Ther 2008;8:291–298
48. Vliagoftis H, Kouranos VD, Betsi GI, Falagas ME. Probiotics
for the treatment of allergic rhinitis and asthma: systematic review
of randomized controlled trials. Ann Allergy Asthma Immunol
2008;101:570–579
49. Vignola AM, Humbert M, Bousquet J, Boulet LP, Hedgecock S,
Blogg M. Efficacy and tolerability of anti-immunoglobulin E
therapy with omalizumab in patients with concomitant allergic
asthma and persistent allergic rhinitis: SOLAR. Allergy
2004;59:709–717
50. Chen GZ, Chen GL. Effects of Cordyceps sinesis on murine T
lymphyocyte subsets. Chinese Medical Journal-Peking
1991;104:4-8
51. 楊賢鴻，Yearbook of Chinese Medicine and Pharmacy 2006;
24(1):357-398
52. 李平，玉屏風散加味治鼻鼽。陝西中醫1997;(5):233-234
53. 徐鴻慶，160 例過敏性鼻炎的症治。新中醫1996;(12):191
54. 周维榕，辨症論治為主治療過敏性鼻炎80例。中西醫结合雜誌
1990;10(9):5551
55. 王衛剛， 針灸治療過敏性鼻炎臨床現狀。陝西中醫學院學2002
;25(2):63-66
56. Duthie MS, Kimber I, Dearman RJ, Norval M. Differential
effects of UVA1 and UVB radiation on Langerhans cell migration in
mice. J Photochem Photobiol B: Biol.2002;57:123–131
57. El-Ghorr AA, Norval M. Biological effects of narrow-band
(311nm TL01) UVB irradiation: a review. J Photochem Photobiol
B: Biol.1997;38:99–106
58. Krutmann J. Therapeutic photoimmunology: photoimmunological
mechanisms in photo(chemo)therapy. J Photochem Photobiol B:
Biol.1998;44:159–164
59. Vermeer BJ, Hurks M. The clinical relevance of
immunosuppression by UV irradiation. J Photochem Photobiol.B:
Biol.1994;24:149–154
60. Salo HM, Jokinen EI, Markkula SE, Aaltonen TM, Penttila HT.
Comparative effects of UVA and UVB irradiation on the
immune system of fish. J Photochem. Photobiol B: Biol.
2000;56:154–162
61. Kalimo K, Koulu L, Jansen CT. Effect of a single UVB or PUVA
exposure on immediate and delayed skin hypersensitivity reactions
in humans. Correlation to erythemal response and Langerhans cell
depletion. Arch Dermatol. Res.1983;275:374–378
62. Garssen J, Vandebriel RJ, de Gruijl FR, Wolvers DA, van Dijk
M, Fluitman A, van Loveren H. UVB exposure-induced systemic
modulation of Th1- and Th2- mediated immune responses.
Immunology1999;97:506–514
63. Nghiem DX, Kazimi N, Mitchell DL, Vink AA, Ananthaswamy
HN, M.L. Kripke, S.E. Ullrich. Mechanisms underlying the
suppression of established immune responses by ultraviolet
radiation. J Invest Dermatol.2002;119 :600–608
64. Garssen J, van Loveren H. Effects of ultraviolet exposure on the
immune system. Crit Rev Immunol.2001; 21 :359-397
65. Morita A, Werfel T, Stege H, Ahrens C, Karmann K, Grewe M,
Grether-Beck S, Ruzicka T, Kapp A, Klotz LO, Sies H,
Krutmann J. Evidence that singlet oxygen-induced human T helper
cell apoptosis is the basic mechanism of ultraviolet-A radiation
phototherapy. J Exp Med.1997;186 :1763–1768
66. Aragane Y, Kulms D, Metze D, Wilkes G, Poppelmann B, Luger
TA, Schwarz T. Ultraviolet light induces apoptosis via direct
activation of CD95 (Fas/APO-1) independently of its ligand
CD95L. J Cell Biol.1998; 140:171–182
67. Danno K, Fujii K, Tachibana T, Toda K, Horio T. Suppressed
histamine release from rat peritoneal mast cells by ultraviolet B
irradiation: decreased diacylglycerol formation as a possible
mechanism. J Invest Dermatol.1988;90:806–809
68. Kronauer C, Eberlein-Konig B, Ring J, Behrendt H. Influence of
UVB, UVA and UVA1 irradiation on histamine release from
human basophils and mast cells in vitro in the presence and
absence of antioxidants. Photochem Photobiolo. 2003;77:531–534
69. Gollhausen R, Kaidbey K, Schechter N. UV suppression of
mast cell-mediated wealing in human skin. Photodermatol.
1985;2:58–67
70. Vocks E, Stander K, Rakoski J, Ring J. Suppression of
immediate-type hypersensitivity elicitation in the skin prick test by
ultraviolet B irradiation. Photodermatol Photoimmunol Photomed.
1999;15:236–240
71. Novak Z, Bonis B, Baltas E, Ocsovszki I, Ignacz F, Dobozy A,
Kemeny L. Xenon chloride ultraviolet B laser is more effective in
treating psoriasis and in inducing T cell apoptosis than
narrow-band ultraviolet B. J Photochem Photobiol. B: Biol.
2002;67:32–38
72. Bonis B, Kemeny L, Dobozy A, Bor Z, Szabo G, Ignacz F. 308 nm
UVB excimer laser for psoriasis. Lancet 1997;350:1522
73. Kemeny L, Bonis B, Dobozy A, Bor Z, Szabo G, Ignacz F. 308-nm
excimer laser therapy for psoriasis. Arch Dermatol.
2001;(137):95–96
74. Zsanett Csoma , Ignacz F , Bor Z, Szabo G , Bodai L ,Dobozy A,
Kemeny L. Intranasal irradiation with the xenon chloride
ultraviolet B laser improves allergic rhinitis. Journal of
Photochemistry and Photobiology B: Biology 2004;75:137–144
75. 陳美蘭，三伏灸治療過敏性鼻炎50例 。湖南中醫雜誌 2006;22
(5)：61
76. 姬曉蘭、宋晓平，單用斑蝥天灸治療過敏性鼻炎的臨床研究 。
新疆中醫藥 2006;24(4)：42-45
77. 郎笑梅，夏季穴位敷貼治療過敏性鼻炎30例。中醫藥臨床雜誌
2OO7;19 (1)：31
78. Tai CJ, Wang PC. Comparisons of two intranasal corticosteroid
preparations in treating allergic rhinitis. Otolaryngology and Head
Neck Surgery 2003;129(5):518-525
|